ArticleTransplant infectious disease : an official journal of the Transplantation Society2024

Breakthrough SARS-CoV-2 infections among recipients of tixagevimab-cilgavimab prophylaxis: A citywide real-world effectiveness study.

Frances R Lendacki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.